Health

Science Nonfiction

“I have a whole new lease on life. I’m here when I probably wouldn’t be,” says Dale. “I actually had a scan and was given the all clear. I’m officially a survivor.”

“I have a whole new lease on life. I’m here when I probably wouldn’t be,” says Dale. “I actually had a scan and was given the all clear. I’m officially a survivor.”

In January 2016, 60-year old Ian Dale of Cary, NC, was diagnosed with an aggressive form of anaplastic large cell lymphoma. Despite undergoing traditional treatments, the chemotherapy and radiation couldn’t stop his cancer from relapsing. For Dale, the UNC Bone Marrow and Stem Cell Transplant Program offered a last ray of hope in the form of a clinical trial; one that genetically alters his immune cells (T-cells) to recognize and destroy cancer cells with limited side effects. Dale, who is now officially in remission, is living proof that cellular immunotherapy shows great promise.

“I have a whole new lease on life. I’m here when I probably wouldn’t be,” says Dale. “I actually had a scan and was given the all clear. I’m officially a survivor.”

UNC Lineberger is one of only a few centers nationally to have the capabilities to develop and deliver this line of treatment. Trials are in the works for up to a half dozen types of cancer that could respond to this type of treatment. Immunotherapy represents the powerful future of cancer treatment, and we are helping to lead the way— and more important, clear the path to improved outcomes for patients.

 

UNC Lineberger Comprehensive Cancer Center Funding Priorities

    Explore More Stories

    Tom, Wilson, and Nancy Chewning stand in their house.
    Donor

    Venture Philanthropy

    Investing in nascent research ideas may unlock future cures

    Dr. Lisa Carey wears a white lab coat and poses in a hospital hallway.
    Donor

    Supporting Innovative Cancer Treatments

    Donor gives $25 million to establish UNC Lineberger Center for Triple Negative Breast Cancer.

    Rich Preyer and Marilyn Jacobs Preyer
    Donor

    Reducing Breast Cancer Disparities And Barriers To Care

    Rich Preyer and Marilyn Jacobs Preyer have donated $1 million to support UNC Lineberger Comprehensive Cancer Center’s Carolina Breast Cancer Study

    Donor

    Grateful patient and husband establish breast cancer research fund

    Ensuring access to the most advanced care

    Health

    Deepening Our Understanding

    Using next generation sequencing to better understand COVID-19

    Health

    Precision Cancer Treatments

    "It's an exciting approach; we hit the tumor hard with little toxicity, leaving room for other therapy."